Characterization of the Sneathia amnii Cytotoxin and its Potential Role in Health Disparities Affecting Women of African Ancestry by Amankwa-Asare, Ivypel
University of Lynchburg 
Digital Showcase @ University of Lynchburg 
Undergraduate Theses and Capstone Projects Student Publications 
Spring 5-2021 
Characterization of the Sneathia amnii Cytotoxin and its Potential 
Role in Health Disparities Affecting Women of African Ancestry 
Ivypel Amankwa-Asare 
amankwaasare_i@lynchburg.edu 
Follow this and additional works at: https://digitalshowcase.lynchburg.edu/utcp 
 Part of the Women's Health Commons 
Recommended Citation 
Amankwa-Asare, Ivypel, "Characterization of the Sneathia amnii Cytotoxin and its Potential Role in Health 
Disparities Affecting Women of African Ancestry" (2021). Undergraduate Theses and Capstone Projects. 
193. 
https://digitalshowcase.lynchburg.edu/utcp/193 
This Thesis is brought to you for free and open access by the Student Publications at Digital Showcase @ 
University of Lynchburg. It has been accepted for inclusion in Undergraduate Theses and Capstone Projects by an 





Characterization of the Sneathia amnii Cytotoxin and its Potential Role in Health Disparities 
Affecting Women of African Ancestry 
Ivypel Obaapa Amankwa-Asare 
Senior Honors Project 
Submitted in partial fulfillment of the graduation requirements 
of the Westover Honors College 
Westover Honors College 
May 2021 
Jamie L. Brooks, PhD 
Ghislaine L. Lewis, PhD 
Beth Savage, PhD 
ii 
Table of Contents 
List of Figures .................................................................................................................................. i 
List of Tables .................................................................................................................................. ii 
List of Abbreviations ..................................................................................................................... iii 
Abstract ........................................................................................................................................... v 
Introduction..................................................................................................................................... 1 
I. Health Disparities in Research............................................................................................ 1 
II. Healthy Vaginal Microbes and the Microbial Profiles of Women of African ancestry ..... 2 
III. Bacterial vaginosis .............................................................................................................. 3 
IV. Preterm birth ................................................................................................................... 4 
V. Sneathia Amnii.................................................................................................................... 5 
VI. The exotoxin CptA.......................................................................................................... 7 
VII. Research Objectives........................................................................................................ 8 
Materials and Methods.................................................................................................................. 10 
Results........................................................................................................................................... 18 
Discussion ..................................................................................................................................... 33 
References..................................................................................................................................... 36 
i 
List of Figures 
Figure 1: Schematic of representation of full length CptA............................................................. 8 
Figure 2: pET32a cloning plasmid expression vector................................................................... 12 
Figure 3: Purification of S. amnii full length CptA recombinant proteins ................................... 23 
Figure 4: Purification of CptA CTerm (98 kDa) and full-length CptA (235 kDa)....................... 25 
Figure 5: Repeated Purification of CptA CTerm (98 kDa) and NTerm (163 kDa). ..................... 26 
Figure 6: Adherence of CptA N-Term and C-Term peptides to HeLa cells................................. 27 
Figure 7: Both CptA N-Term and C-Term bind to HeLa cells..................................................... 28 
Figure 8: Full Length CptA hemolytic activity on human red blood cells. .................................. 29 
Figure 9: Cytotoxic assay using N-terminal and C-terminal domain of CptA ............................. 30 
Figure 10: CptA’s C-term blocked cytotoxic activity of full-length CptA in HeLa Cells. .......... 31 
Figure 11: Homology model of full length CptA toxin modeled after c3fy3A_. ......................... 32 
ii 
List of Tables 
Table 1: Plasmid and bacterial strains. ......................................................................................... 10 
iii 
List of Abbreviations 
Amp ampicillin 
B. pertussis Bordetella pertussis 
bp base pair 
BV bacterial vaginosis 
BVAB1 Bacterial Vaginosis-Associated Bacterium 1 
BVAB2 Bacterial Vaginosis-Associated Bacterium 2 
C-term Carboxy- terminal domain 
CptA Cytopathogenic toxin A 
ddH2O double-distilled water 
DNA Deoxyribonucleic acid 
E. coli Escherichia coli 
EDTA ethylenediamine tetraacetic acid 
EMEM minimum essential media 
Fha filamentous hemagglutinin adhesin 
gDNA genomic DNA 
His Histidine 
IM imidazole 
IPTG Isopropyl -D-1- thiogalactopyranoside 
kDa kilodalton 
L Liters 
L. crispatus Lactobacillus crispatus 
L. gasseri Lactobacillus gasseri 
L. iners Lactobacillus iners 
LB Luria-Bertani 
lbs Pounds 
Mb mega base 
ml milliliter 
mM millimolar 
MW molecular weight 
N-term Amino-terminal domain 
NIH National Institutes of Health 
nm nanometer 
OD optic density 
P. mirabilis Proteus mirabilis 
PBS phosphate buffered saline 
PBST phosphate buffered saline supplemented with 0.05% Tween 20 
PCR polymerase chain reaction 
PTB Preterm Birth 
PVD pelvic inflammatory disease 
PVDF polyvinylidene fluoride 
RNA ribonucleic acid 
RPM revolutions per minute 
rRNA ribosomal RNA 
S. amnii Sneathia Amnii 
 
iv 
SDS-PAGE sodium dodecyl sulphate–polyacrylamide gel electrophoresis 
Sn35 Sneathia Amnii strain 35 
STD sexually transmitted disease 
TAE tris-acetate-EDTA buffer 
TPS two-partner secretion 




VCU Virginia Commonwealth University 
λ lambda 
C degrees centigrade 
v 
Abstract 
Women of African descent are more likely to develop bacterial vaginosis (BV) and bear twice 
the risk of preterm birth and the increased risk of other pregnancy complications. Sneathia amnii 
is a pathogenic anaerobe found in the female urogenital tract that is associated with adverse 
outcomes such as preterm birth, BV, and chorioamnionitis. S. amnii has been found at a greater 
prevalence in the vaginal microbiota of women of African ancestry, which links it to a potential 
role in the disparities observed in health outcomes for these women. S. amnii encodes the 
cytopathogenic toxin A (CptA), an exotoxin that perforates fetal membranes and lyses red blood 
cells. This study seeks to determine which domain of the cytotoxin (N or C-terminal) is 
responsible for the cytotoxic and hemolytic activity. Our work has revealed that the C-terminal 
domain is involved in binding to some host cell surface receptors and that the N-terminal domain 
is the pore-forming domain. Our work also found evidence that the C-terminal binding domain 
can competitively inhibit the cytolytic activity of full-length CptA, which suggests that the toxin 
binds to a specific receptor and that binding is saturable. Advances in our understanding of CptA 
and S. amnii pathogenicity will lead to a more educated approach to therapeutic intervention and 
may reduce health disparities in gynecologic and obstetric complications associated with the 
vaginal microbiome. 




I. Health Disparities in Research 
Women of African are amongst people of minorities that are less likely to be included in 
research studies. Although National Institutes of Health (NIH) Revitalization Act dictate the 
inclusion of racial minorities in studies conducted in NIH-funded biomedical research, women of 
African ancestry continue to still be underrepresented in research pertaining to diseases/ 
conditions that particularly affect their lives (Chinn et al 2021). Conversely, representation of 
people of European ancestry continues to be prevalent in biomedical research (Bentley et al. 
2020). This is troublesome as race and social factors influence the disease risk (Chen et al. 
2014). Furthermore, women of African ancestry are at a higher disproportionate for health 
disparities as issues pertaining to them are either overlooked, and women of the European 
ancestry are set up as the standard for comparative analysis of disease risk. Therefore, based on 
data presented for white women as well as interventions set in place for them are use across the 
board to mitigate issues that affect subethnic groups. 
Due to the lack of representation, women of African ancestry continue to face health 
disparities as they exist in limited research, therefore limited data about conditions that plague 
them and insufficient answers/ treatments to mitigate their problems proving detrimental to their 
health and mortality overall (Chinn et al. 2021). Furthermore, the lack of representation for 
women of African descent in research participation takes out the unique diverse perspective and 
conditions that can be studied, limiting the scope of understanding in research, and diminishing 
significant advancement to the field (Bentley et al. 2020). Thus, it is imperative to increase 
inclusion of minorities especially women of African ancestry to further understand human 
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biology, disease risks and to generate appropriate data that is truly representative of the 
population (Bentley et al.2017). 
II. Healthy Vaginal Microbes and the Microbial Profiles of Women of African ancestry 
A healthy vagina is colonized by Lactobacillus species that produce lactic acids to 
maintain the vaginal pH of less than 4.5 (Fettweis et al. 2014; Jefferson 2012). The acidity of the 
vaginal is essential for Lactobacillus species like L. crispatus to maintain a healthy microbial 
community in the vagina by secreting lactic acid, hydrogen peroxide, and bacteriocins to protect 
the vagina from colonization by other species (Jefferson 2012). The abundance of L. crispatus, 
one of the stable Lactobacillus species, reduces the competition of other species that are instable 
and pathogenic while L. iners, a less stable species, produce low lactic acid concentrations and 
are dominant in higher vaginal pH (Verstraelen et al. 2009; Jefferson 2012; Vaneechoutte 2017). 
Therefore, the reduction of various lactobacillus species reduces microbial protection against 
idiopathic diseases such as bacterial vaginosis, pelvic inflammatory disease (PVD), and increases 
the risk of experiencing preterm birth in women (Bayar et al. 2020; Jefferson 2012). 
The microbial profiles of women of African American ancestry are more diverse because 
they are low abundance of Lactobacillus bacteria and have high diversity profiles of anaerobic 
pathogenic species (Fettweis et al. 2014). The abundance is relatively small in comparison to 
women of European ancestry because the vaginal samples of women of African ancestry their 
community is colonized with different dominant species of both Lactobacillus and anaerobic 
species (Fettweis et al. 2014). The vaginal microbial profiles of healthy nonpregnant women of 
African ancestry were populated with L. iners, Gardenella vaginalis, Parvimonas, Mycoplasma 
hominis, and anaerobes like Sneathia, Porvetella species, BVAB1 and BVAB2, in comparison to 
profiles of women of European ancestry which were predominantly populated with L. crispatus, 
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L. iners, L. gasseri, Staphylococcus species and Gardenella vaginalis (Fettweis et al. 2014). 
These bacterial species put African American women two times more at the risk of dealing with 
negative pregnancy outcomes in comparison to women of European ancestry (Fettweis et al. 
2014). Women of African ancestry compared to women of European descent are more likely to 
exhibit microbial diversity, and they are more likely to contract bacterial vaginosis (BV), which 
increases their risk for preterm birth (Fettweis et al. 2014). 
III. Bacterial vaginosis 
The known cause of vaginal inflammation and the disturbance of the vaginal microbiome 
is from bacterial vaginosis (BV) (Koumans et al. 2007). According to the National Health and 
Nutrition Examination Survey conducted from 2001-2004, BV is prevalent at 29.2% in women 
of all demographics within childbearing age (14-49), and 51.4% more prevalent in women of 
African ancestry (Koumans et al. 2007). Similar studies that supported the prevalence of BV in 
women of African ancestry reported that samples from women from ages 18 to 44 nonpregnant 
women of which, 330 women were of European ancestry and 960 were women of African 
ancestry, 22.8% of the African American women were diagnosed BV and only 6.5% in women 
of European Ancestry (Fettweis et al. 2014). The study also concluded that risk factors for BV 
include race/ethnicity, sexual partners, and in women with high frequencies of douching. Based 
on sociodemographic factors, BV prevalence as high as the sexual partners increased when 
looking at race (Koumans et al. 2007). BV is associated with many health risks including 
susceptibility of HIV and other STIs as well as with the rates of PTB seen in women of African 
ancestry. Pregnant Black women were more likely to experience adverse pregnancy outcomes 
like give birth prematurely due to the prevalence of recorded BV (Koumans et al. 2007). Thus, 
BV causes shifts in microbial community, which give rise to opportunistic microbes such as 
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Sneathia amnii, which appears to be innocuous in the uterine cavity but becomes pathogenic 
when the bacteria ascend the vaginal tract into the amniotic cavity. 
IV. Preterm birth 
Preterm birth (PTB), defined as a live birth less than the 37 weeks gestation period, is a 
universal health issue. Preterm birth is the major cause of the increase in neonatal mortality and 
morbidity rates worldwide (Giurgescu et al. 2013; Walani 2020). According to the PTB 
consensus from 2010, 184 countries, more than 25 million neonates are born preterm worldwide 
(Walani 2020). Similarly, WHO reports that a global estimate of 13 million–17 million births are 
preterm births with high rates, approximately 81.1% of these preterm births, occurring in South 
of Asia and sub-Saharan Africa (Chawanpaiboon et al.2018). Of the millions of preterm births 
worldwide, an estimated one million annual neonates deaths due to preterm birth complications 
(Walani 2020). 
PTB is categorized into different gestational ages. Extreme preterm is classified by birth 
less than 20 weeks of gestation. Very Preterm Birth is noted by a gestation period more than 28 
weeks but less than 32 weeks, and moderate-to-late preterm are births occurring between 32 
weeks and 37 weeks (Jefferson 2012). Based on evidence from 67 countries, an estimate of 
84.7% of PTB are grouped as moderate-to-late preterm births, and 11.3% are considered very 
preterm births. Only 4.1% PTB occur within less than 28 weeks gestation period globally 
(Chawanpaiboon et al. 2018). Of the estimate 15 million global score of annual preterm births, 
an estimate of 750,000 babies is considered extreme preterm deliveries (Walani 2020). Preterm 
birth neonates born less than 32 weeks and weigh less than 3.3lbs have lowest survival rates 
(Goldenberg et al. 2000). 
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V. Sneathia Amnii 
Sneathia amnii is a newly recategorized anaerobe pathogen once classified under the 
Leptotrichia genus and was assigned the strain type named Sn35 (Collins et al. 2001; Harwich et 
al. 2012). S. amnii was first isolated from mid vaginal samples of 736 women in outpatient 
clinics across the state of Virginia (Harwich et al. 2012). In past studies, Sneathia species 
including S. amnii was found in amniotic fluid collected from pregnancies associated with 
preterm labor (Han et al. 2009). Research hypothesizes that intrauterine infections and 
inflammations that are linked to preterm birth is through the ascension of pathogenic bacteria 
like S. amnii from the cervix into the placenta and fetal membranes as noted in diseases like 
chorioamnionitis where fluid from membrane rupture indicated the invasion of microbes 
(Jefferson 2012). This means that preterm-associated bacteria species like cross from the 
mother’s side to the fetal side and causes intra-amniotic infections and inflammation that lead to 
preterm birth (Han et al. 2009). 
According to recent studies, Sneathia amnii persists as a prevalent bacterial species in the 
urogenital tract of women of African ancestry (Harwich et al. 2012; Fettweis et al. 2019). 
Although Sneathia is prevalent in the human female vagina, it is understudied pathogen, which 
can also infect men (Gentile et al. 2020;). Additionally, due to the lack of abundant research on 
the bacteria and its role in the reproductive tract, there is hardly any published research about S. 
amnii infections outside the reproductive tract (Duployez et al. 2020). The presence of Sneathia 
in the uterine cavity is associated with negative pregnancy outcomes, perinatal and neonatal 
complications as well as obstetrics complications (Harwich et al. 2012). The complications 
include bacterial vaginosis, chorioamnionitis, amnionitis, preterm labor, stillbirth, and 
spontaneous abortions in pregnant women and women of childbearing age (Harwich et al. 2012). 
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It is also implicated in clinical conditions like PVD, infertility, salpingitis, and septic arthritis, 
and it is involved in neonatal and perinatal complications such as meningitis (Gentile et al. 2020) 
bacteremia. In men, it can lead to nongonococcal urethritis in men (Gentile et al. 2020). 
Sneathia amnii is a gram-negative anaerobe with long-bacilli shaped morphology and 
rounded ends (Harwich et al. 2012). Sneathia amnii requires specific medium human blood for 
optimal growth and yields small flat colonies on blood agar in an anaerobic chamber (Gentile et 
al 2020; Duployez et al. 2020). Moreover, based on the study conducted as part of the Vaginal 
Human Microbiome Project at VCU. Sneathia species was determined as a predominant taxa in 
the vaginal microbiome (Harwich et al. 2012). The study derived this conclusion based on the 
abundance of Sneathia amnii identified by 16S rRNA analysis with more than 70% reads using a 
0.1% abundance threshold and about 76.3% reads recognized as S. amnii presence in mid-
vaginal samples, indicating its prevalence in the vaginal microbiome (Harwich et al. 2012). 
Furthermore, this bacterium is the smallest sequenced fusobacteriacae and its genomic size is 
approximately 1.34M base pairs with 1.2M bases making the DNA coding region (Harwich et al. 
2012). Close analysis of the genome showed that the bacterium has a GC content of 28.3% and 
852 genes associated with a putative function (Harwich et al. 2012). 
S. amnii encodes an exotoxin, component A of the TPS called cytopathogenic toxin A 
(CptA), which has cytotoxic and hemolytic capabilities. Using this exotoxin, Sneathia amnii 
perforates membranes and lyses red blood cells (Gentile et al 2020). S. amnii genome contain 
tandem genes for encoding two-partner secretion system that allows CptA to be exported into 
epithelial cells to induce pore formation (Gentile et al. 2020). The bacteria’s genome contains 
tandem genes that allow the secretion of the toxin via a Type Vb two-partner secretion (TPS) 




induce osmolysis activity (Gentile et al. 2020). The Type Vb two-partner system is used by many 
fastidious gram-negative bacteria to transport virulence factors like hemolysins, endotoxins and 
other cytotoxins (Gentile et al. 2020). The two-partner secretion system has an effector coupled 
with a beta barrel transporter that forms in the outer membrane to delivers CptA into epithelial 
cells (Gentile et al. 2020). The CptA is the effector that the cognate transporter transports into the 
outer membrane of cells (Gentile et al. 2020). Based on in-silico analysis of the toxin, it shares 
similarities with well identified and studied region in Type Vb two-partner secretion system 
found in Bordetella pertussis named filamentous hemagglutinin adhesin (Fha). Based on the 
well-studied research about Fha, it is depended on its transporter, FhaC, to enter the outer 
membrane to form beta-barrel forming pores (Mazar and Cotter 2007). Additionally, the 
homology between CptA and Fha is 46% with only 261 aligned residues to CptA residues 
(Gentile et al. 2020). 
VI. The exotoxin CptA 
The toxin comprises of 1,881 amino acids and has an approximate molecular weight of 
201kDA. It is a large protein, and the isoelectric point is 9.4 (Gentile et al. 2020). As mentioned 
previously, CptA is best modelled after Fha in Bordetella pertussis with only 29% identity and 
46% similarity (Gentile et al. 2020). CptA toxin has two separable domains hypothesis to have 
independent functions – the amino-terminal domain (N-term) and the carboxy-terminal domain 
(C-term) (Fig. 1). The N-term of the CptA contain the CptA gene locus which encode the CptA 
protein that is responsible for pore-formation in cells (Gentile et al. 2020). The full length CptA 
is approximately 6300 nucleotides long (Fig. 1). The N-term domain is 3,978 nucleotides in 
length from the 5’ end of the cptA gene, and the C-term domain is 2370 nucleotides in length 
from the 3’ end of the cptA gene (Fig. 1). Based on analysis, the full-length CptA has a protein 
lptANoSigBam (70 .. 99) (4024 .. 4048) CptARepeats4VCptANTermRev (4024 .. 4048) CptBSTOPRevXh, 
2000 4000 6000 
N-Termlnal domain > '---- -----
C-Terminal Domain 
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size of 235 kDa. The amino terminal domain permeabilizes cells and has a protein size of 
163kDa. On the other hand, the C-term is involved in binding to host surface receptors on 
epithelial cells and is made up of 6 consecutive tandem repeats of 80 amino acids. The C-term 
has protein size of the C-term is 99 kDa. There is little known about CptA and how it works. 
Figure 1: Schematic of representation of full length CptA. 
Figure 1: Schematic of representation of full length CptA and N-term and C-term domains of 
CptA. Shown is the amino-terminal domain and the carboxy-terminal domain with appropriate 
nucleotide length. Adapted from Dr. Jefferson. 
VII. Research Objectives 
Based on previous works, researchers have implicated S. amnii in gynecologic and 
obstetric complications associated with the vaginal microbiome. Furthermore, the exotoxin, 
CptA, encoded by S. amnii is known to perforate membrane cells and lyse red blood cells. There 
is little known about CptA and how it works. Therefore, advances in our understanding of CptA 
and S. amnii pathogenicity will lead to a more educated approach to therapeutic intervention and 
may reduce health disparities in women of African ancestry. Thus, the goal of this research is to 
discover CptA and its role in host-pathogen interactions by establishing and investigating the 
following objectives in this study: 
1. Express the Full length CptA and the CptA domain peptides in E. coli cells and 
purifying them. Our work revealed that the peptides could be successfully 
expressed and purified. 
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2. Determine which domain of CptA is responsible for the cytotoxic and hemolytic 
activity. Our work has revealed that the C-terminal domain is involved in binding 
to the host cell surface and that the N-terminal domain is the pore-forming 
domain. 
3. Identify the role of C-terminal binding domain in host-pathogen interactions. Our 
work found evidence that the C-terminal binding domain can competitively 
inhibit the cytolytic activity of full-length CptA, which suggests that the toxin 




Materials and Methods 
Culture conditions. The bacterial strain and plasmids used in this study are listed in Table 1. 
Bacterial strain used in this study was BL21(DE3) pLysS + pRIL E. coli cells. The E. coli strain 
was grown aerobically at 37C on Luria-Bertani (LB) broth medium and agar plates containing 
100ug/ml ampicillin overnight. E. coli grown in liquid cultures were incubated aerobically in LB 
broth at 37C in an incubator shaker (Incubator Shaker Model G25 New Brunswick Scientific 
Co, Inc, Edison NJ) with heater for optimal oxygen supply to E. coli cells. 
Table 1: Plasmid and bacterial strains. 
Plasmid Description Source 
pET32a E. coli expression vector with T7 promoter, beta-lactamase gene 














E. coli strain Description Source 
BL21(DE3) 
pLysS + pRIL 
E. coli cells 
Chemically competent cells derived from E. coli BL21 strain. 
The BL21 strain is protease deficient. DE3 phage provides T7 
to drive gene expression. pLysS plasmid suppresses basal 
expression of T7 RNA polymerase until induction by IPTG. 
pRIPL plasmid contains extra copies of genes that encode 
tRNAs that are rare in E.coli but common in S. amnii. 
Stratagene 
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Agarose gel. 1% agarose-LE gel in 1X TAE. Ethidium bromide was added to the solution before 
pouring. 6X loading dye was added to DNA samples. The gel was run at 100 volts in 1X TAE 
buffer for 35 minutes. After separation, the DNA fragments were visualized under UV light. 
DNA size was determined by comparing the DNA sample bands against λ/HindIII fragments. 
Protein expression. The pET32a vector was used to express fragments of CptA proteins. 
Proteins were expressed from the pET32a plasmids through the T7 promoter (Fig. 2). An 
expression strain containing the pRIPL plasmid was used because certain codons, including 
argU (AGA, AGG), ileY (AUA), proL (CCC), leuW (CUA) are rarely used in E. coli but much 
more commonly found in the cptA gene from Sneathia amnii. The cells were inoculated in LB 
medium with chloramphenicol and ampicillin overnight and placed in a 37°C shaker (Brunswick 
Scientific Co.; Edison NJ). The cells were subcultured in 500 ml LB broth to mid-log phase at 
37°C before pET32a vector with CptA fragment was added and incubated in the shaker 
(Brunswick Scientific Co.; Edison NJ) for 2 hours. 
T7 promoter ► lac operator Xba I ~ 
T AA T ACGACTC AC TAT AGGGGAA TTGT GAGCGGAT AACAA TTCCCCT CT AGAAA T AA TT TTGT TT AAC TTT AAGAAGGAGA 
Trx•Tag Msc I Hie•Tag 
TAT ACAT ATGAGC .. . 315bp .. . CTG GCCGGTTC TGGTTCTGGCCA T ATGCACCATCA TCATCATC A TTC TTCT GGTC TGGTGCCACGCGGTTC T 
He t Ser 105cc .. . Leu A I oG l ySe rG l ySerG I yHi sHe t H I sH I sH I sH I sH I sH i sSerSerG I yleuVo IProArgG I ySe r 
S•Tag ~ S•Tag ~;Ji #6~3 thrombin I 
GGT ATGAAAGAAACCGCTGC TGC T AAA TTCGAACGCCAGCACA TGGACAGC CCAGATCT GGGT ACCGACGACGAC GACA AG 
GI yMetL ysG I uThr Al oA I oA l olys PheG I uArgG I n H I sMe tAspSer Pro A spleuG I yThrAspAspAsp AspL ys . 
i:£T-32a(+) Eag I Ava I I cntcrok1naec 
Nool EooRV&mt-tl EooR I Sacl Sa/I Hirx:1 111 Noll Xhol Hio·Tag 
GCCATGGCTGA TA TCGGAT CCGAA TTC GAGC TCCG TCGACAAGCTTGCGGC CGCACTCGAGCACCACCACC ACCACCAC TGAGATCCGGCT GCT AA 
A I oMetA I oAs p I I eG I ySerG I uPheG I uleuArgArgG I nA I oCysG I yArgThrArgA I oProP roPr oProProleuArgSerG I yCysEnd 
~I T7 terminator 
CAAAGCC CGAAAGGAAGCT GAGT TGGC TGCTGCCACCGC TGAGCAAT AACT AGCA T AACCCCTTGGGGCC T CT AAACGGGTCT TGAGGGGT TTTT TG 
L ysPr oG I u Argl ysleuSer T rpleuleuProProleuSe rAsnAsnE nd 
T7 terminator P'irnet" #69337-3 
pET-32a-c(+) cloning/expression region 
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Figure 2: pET32a cloning plasmid expression vector. 
Figure 2: pET32a cloning plasmid expression vector with T7 promoter, 6X His-Tag and the S-
Tag. Figure 2 cited from Novagen (LaVillie 1993). 
Polyacrylamide gel electrophoresis. Protein gels were run using the NuPAGE SDS-PAGE 
(Invitrogen). The running buffer for SDS-PAGE gel was prepared with 800 ml 1X MES running 
buffer consisting of 20 ml of MES SDS running buffer and 760 ml of ddH2O. 10 ul NuPAGE 4X 
LDS Sample Buffer and 4 ul reducing buffer agent was added and mixed into 30 ul of sample. 
The samples were incubated in a heat block for 10 minutes, at 85°C and 20 ul of sample was 
loaded into the wells of NuPAGE 4-12% Bis-Tris 1.0 mm Gel. The gel was run at 200 volts in 
1X NuPAGE Running Buffer for 30 minutes. Protein band size was determined by comparing 
the protein sample bands against BLUEstain protein ladder. After electrophoresis, the gel was 
washed twice with ddH2O and placed on an orbital shaker to develop and for visualization. 
Lysis of E. coli for the Purification of recombinant proteins. Protein was expressed in the 
BL21(DE3) pLysS + pRIL strain of E. coli. The frozen induced BL21(DE3) pLysS + pRIL + 
pET32a pellet was resuspended on ice with lysis buffer made using 250ml of 1X PBS and 100 
mM NaCl (1.46 g) and one protease inhibitor tablet [cOmplete, EDTA-free protease inhibitor 
cocktail tablet] (Roche Diagnostics GmbH, Germany). The resuspended pellet was lysed with a 
French press 4 times. After lysis, the lysate was spun down in a centrifuge at 25000 RPM for 20 
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mins at 4°C. The supernatant was filtrated using a syringe capped with a pre-filter and a 0.45 um 
pore filter. 
Protein Purification by Metal Ion Chromatography. The filtered protein was purified by 
nickel ion affinity chromatography. The purification column was prepared with 2.5 ml of 
Probond™ Resin (nickel beads) (Invitrogen Life Technologies Carlsbad, CA), which was 
washed with 11 ml of ddH2O and equalized with 10 ml of 100 mM NaCl and 10X PBS buffer. 
The ProBond buffer was made with 25 ml of 10X PBS and 100 mM NaCl and detergent. The 
elution buffer was made with 250 ul of Ultra-Pure distilled water and 2.5 ml of 1M imidazole 
(IM). The filtered lysate was first added to nickel column and collected flow through for further 
analysis for cytotoxicity. The lysate in the resin column was washed 4 times with probond 
buffer, and the column was eluted with elution buffer. The column was eluted with 2 ml of 
dilution of imidazole at 1 M, 500 mM, 250 mM and 125 mM. At each step of the protein 
purification protocol, 50 ul aliquots of each step were saved in -80°C for further analysis. This 
procedure was done in a cold room. The same procedure was done performed with C-term 
fragment. SDS-PAGE Electrophoresis was performed with the saved aliquots to track the 
protein. The samples were prepared for SDS-PAGE using 50 ul of samples, 20 ul loading buffer 
and 7 ul reducing agent and heat in heat block for 10 mins. The 30 ul was loaded into each well 
as well as the 5 ul of molecular ladder. The gel was run for 30 minutes at 200V. 
HeLa Cell Binding Assay and SDS-PAGE gel. HeLa cell monolayers were cultured in T25 
flasks. The media was removed, and the HeLa cells were washed with 5 ml of PBS. Purified, 
recombinant N-term or C-term at a concentration of 5ug protein/mL in PBS or PBS alone, was 
added to T25 flasks 7 and the samples were incubated in 5% CO2 incubator for 15 minutes. The 
cells were scrapped into 1 ml of SLS NuPAGE loading buffer (Invitrogen), sonicated for 30 
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seconds to break up DNA and put on heat block for 10 minutes at 85°C. Separate 
microcentrifuge tube containing either N-term or C-term peptides was mixed with a reducing 
buffer and put on a heat block with the rest of the samples. 20 ul of sample was loaded into each 
well of NuPAGE 4-12% Bis-Tris 1.0 mm Gel. The organization of the well is listed below: 
1. 5 ul MW size marker 
2. 20 ul of cells alone with PBS 
3. 20 ul of CptA/N-term alone 
4. 20 ul of CptA/N-term + Hela cells 
5. 20 ul of C-term alone 
6. 20 ul of C-term + Hela cells 
The SDS-PAGE gel was electrophoresed at 200V for 30 minutes. 
Prepared the transfer buffer and protein transfer. Transfer buffer was made with 40 ml of 
1X NuPAGE (Invitrogen) added with 610 ml of ddH2O and 150 ml of methanol. A 0.45 um 
PVDF membrane (Invitrogen, Grand Island, NY) was pre-wetted in 100% methanol for 30 
seconds to 1 minute. Transfer filter paper and sponges were soaked and saturated in the transfer 
buffer as well as the PVDF membrane was rinsed with transfer buffer for a few minutes. 
Following polyacrylamide gel electrophoresis, the gel was prepared for transfer by rinsing in 
ddH2O and then placed against the PVDF membrane carefully to eliminate bubbles, which would 
inhibit the transfer of proteins. The gel and PVDF membrane were surrounded by the transfer 
filter paper and sponges to maintain buffer saturation and tight contact between the membrane 
and gel, and the same 1X NuPAGE transfer buffer. The SDS-PAGE electrophoresis gel was run 
for 1 hour at 35 volts. 
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Western blot to detect 6X-His-tagged proteins. The blocking buffer contained 5% skim milk 
diluted in 1 X PBS. The wash buffer was prepared using 1X PBS and 0.05% Tween 20 (PBS-T). 
The PVDF membrane was soaked in the milk blocking buffer made of 5% skim milk diluted in 
10X PBS for 1 hour, while rocking on an orbital shaker at room temperature. The milk blocking 
buffer was removed and replaced with a 1:10,000 dilution of anti-6X HIS Tag primary antibody 
in PBS-T. The PVDF membrane was agitated on the orbital shaker gently for 1 hour. After the 
hour, the solution was poured out and the PVDF membrane washed three times for 5 minutes in 
1X PBS-T. The PVDF membrane was probed with 1:10,000 goat anti-rabbit immunoglobulin-
horseradish peroxidase conjugate (Invitrogen, Grand Island, NY) in 1X PBST for 1 hour at room 
temperature and rocked on the orbital shaker. The PVDF membrane was rinsed at room 
temperature with PBST three times for 5 minutes and once with ddH2O. In the dark room, 
protein bands were developed using the saran wrap and ECL prime kit (GE Healthcare) to detect 
protein and measure the protein size. The blot was incubated in the chemiluminescence 
developing reagent for 1 minute, covered in saran wrap, exposed to X-ray film and developed in 
an X-O-Mat. The bands visualized were compared to BLUEstain protein ladder (Gold-Bio). 
Cell culture. HeLa cells were cultured in a 5% CO2 incubator at 37°C in minimum essential 
media (EMEM) (Quality Biological, Gaithersburg, MD). HeLa cells were viewed under an 
inverted microscope for more than 70% confluence. The old EMEM was aspirated off the HeLa 
cells and discarded. The cells were washed in PBS and aspirated. The adherent cells were then 
covered with trypsin and returned to the incubator at 37°C and 5% CO2 for 5 to 10 minutes for 
the cells to dislodge from the surface of the flask. The EMEM cell media was added to the cells 
and resuspended. The cells were split 1:10 split of cells into a new T25 flask with 1 ml of cell 
and 9 ml of fresh EMEM cell media or 1:20 split with 4 ml of cells into 6 ml of fresh new 
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EMEM. The remaining cells were split into 12 well plates with 0.5 ml per well. The cells were 
incubated in a 5% CO2 incubator at 37°C, and the cells were passed every 4 days. 
Hemolytic Assay. The purified peptides were incubated with human erythrocytes washed in 
PBS for 2 hours at 37ºC. The liberated hemoglobin was measured by optical density at 405nm 
via spectrophotometry (Biomate 3 Thermo Electron). 
Cytotoxic assay with terminal domains of CptA. Cytotoxicity and cell permeabilization were 
monitored using an inverted microscope (EVOS) (Life Technologies, Carlsbad, CA). Media was 
aspirated from the wells, and the cells were washed with PBS. PBS was added to each well, and 
30 ul of N and C term peptides were added to HeLa cells and incubated in a 5% CO2 incubator at 
37°C for 2 hours. The cells were visualized, and images were taken with an inverted microscope 
EVOS AMEX-100 microscope (Life Technologies, Carlsbad, CA) to examine membrane 
permeability and cell morphology of HeLa cells. Trypan blue (Thermo Scientific, Waltham, 
MA) at 1:3 dilution was added to each cell and let to set for 2-3 minutes. The trypan blue was 
aspirated off the well and viewed under microscopy. The cells were analyzed using trypan blue 
exclusion method. The cytotoxic assay was repeated with saved aliquots from the purification 
steps. 
Cytotoxic assay with terminal domains of CptA at different volumes. The cytotoxic assay 
performed on HeLa cells was done to monitor cytotoxicity and cell permeabilization under an 
inverted microscopy. The old media in the wells in the 24-well plate were aspirated, and the cells 
were washed with PBS. 250 ul PBS was added to each well with the exception of 500 ul added to 
the first column of well-plate. C-term was done with different volumes of C-term added to the 
1st 2nd and 3rd row. 5 ul of C-term was added to the wells across the well plate in the first row. 
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In the second row, C-term was added at 0.5 ul volumes to each well in the second row and 0 ul in 
the 3rd row. The fourth row served as the negative control. 3 ul of CptA was added to each well 
in the first column and serial dilution was carried out by pipetting 250 ul across the wells. The 
HeLa cells were incubated in a 5% CO2 incubator at 37C for 2 hours. The cells were visualized 
under an inverted microscope to examine membrane permeability and cell morphology of HeLa 
cells. Trypan blue at 1:3 dilution was added to each cell and let to set for 2-3 minutes. The trypan 
blue was aspirated off the well and viewed under microscopy. The cells were analyzed using 
trypan blue exclusion method. The cytotoxic assay was repeated with different volumes of C-
term and N-term. 
In silico analysis. FASTA format sequence retrieved from NCBI was used to model the 
structure of toxin. The FASTA sequence of Sneathia amnii CptA document taken from Dr. 
Jefferson and ran that into n-BLAST. Based on Gentile et al. 2020, the CptA toxin was served 
for using command+F with keyword VC03_06090. The derived protein FASTA sequence for 
CptA was run in Phyre 2.0 software at normal mode using the sequence. 
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Results 
The full-length CptA and the domains of CptA, N-term and C-term, were successfully 
expressed and purified. 
The two domains of CptA, the structured amino-terminal, and the globular carboxy-terminal 
domain were cloned into pET32a expression vectors. The proteins were expressed in the 
BL21(DE3) pLysS + pRIL strain of E. coli cells. In Figure 3, full length CptA was purified by 
nickel ion column. Based on the SDS-PAGE analysis, the saved aliquots from the purification 
steps of CptA had faint bands appear at ~240 kDa. The bands did not appear when photographed, 
but when the gel was viewed physically, light band at ~240 kDa was seen in the 10 mM lane, but 
it was not captured on camera. The breakdown of the peptides appeared across all the columns 
with the different dilutions of imidazole. We expected a messy column for the lysate and less 
smearing for 500 mM IM. 
In Figure 4, SDS-PAGE analysis was performed after purification of the full-length CptA 
and C terminal domain of CptA by nickel ion column. In Fig. 4, the proteins of the full length 
CptA and C-term domain were eluted from the nickel beads with 10 mM, 100 mM, or 250 mM 
imidazole. The proteins were seen for the C terminal domain at 98 kDa, and the full-length CptA 
was viewed at 235 kDa. The C-term domain was 80 kDa plus the 17.9 kDa tag. Similar to Fig. 3, 
the breakdown of the peptides was seen with the smearing of the bands. As expected, the 
smearing indicative of protein breakdown was seen in the flow through lane. It is our assumption 
that the breakdown of the peptides may be due to CptA protein being autocatalytic that is why 
we see the other bands appear. This hypothesis needs to be further investigated. Furthermore, 
due to the grand size of the domain terminal peptides, lack of separation of the peptides leads to 
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the smearing. The purified terminal peptides were eluted with and the bands were prominent. 
The peptides of C-term were seen at 98 kDa, and the full length CptA was viewed with bands at 
235 kDa. In Figure 5, the purified domain peptides of C-term and N-term of CptA were 
visualized on SDS-PAGE gel after the peptides were eluted from the nickel beads with 10mM, 
100 mM, or 250 mM imidazole. The C-term domain was 80 kDa plus the 17.9 kDa tag and the 
N-term domain was 145 kDa plus the 17.9 kDa tag. The bands appeared at 98 kDa for C-term 
domain of CptA and 163 kDa at N-term domain of CptA. 
Both the N-term and C-term bound to HeLa cells 
To investigate how the terminal domains of CptA interacted with HeLa monolayers, we 
added the purified domain peptides to HeLa cells and incubated for 15 mins. Then the cells were 
washed in PBS to remove the nonadherent proteins leaving the adherent within the HeLa cells. 
The cells were then sonicated to break up the cells and release the DNA and the samples for each 
adherent domain protein in the HeLa cells were run on an SDS-PAGE gel. The proteins were 
transferred to an PVDF membrane and was probed with both the primary antibody, anti-6X HIS 
Tag, and the secondary antibody, goat anti-rabbit immunoglobulin-horseradish peroxidase 
conjugate, and the bands were visualized by western blot. In Figure 6, the HeLa cells in the 
second lane served as the negative control and showed that the antibodies used for probing did 
not tag the proteins of the HeLa cells as indicative with no bands showing in the lane. Both the 
N-term or C-term peptides alone were added and served as positive control to show where the 
bands were supposed to appear. In Figure 6, in the N-term lane, we see multiple bands appearing 
in the lane. However, this is the only clearly the only visible bands present only in the N-term 
peptide alone lane with less lightly visible bands in the N-term bands added to HeLa cells and C-
term peptide alone and absolutely no bands present in the C-term peptides added to HeLa cells. It 
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was our assumption that the malfunctioning of the western blot and the lack of inaccuracy of 
corresponding bands to the appropriate molecular marker of protein size was due to many 
possibilities including a lower concentration of the C-term peptide being added which although 
appeared on the SDS-PAGE gel, did not transfer to the PVDF, and was lost and that the N-term 
peptide concentration was twice as the concentration of the C-term peptide. Another possibility 
we considered was mutations in E. coli cells at the 6X His tag mutated from Histidine to proline, 
so the primary antibody was unable to probe the peptides. Thus, this was rectified in a second 
Western blot done by Mr. Jacob Raskind of VCU using an antibody for the S-tag as shown in 
Fig. 7. In Figure 7, the bands for the N-term peptide appeared appropriately around 240 kDa. 
However, a second was present, it was our assumption that maybe due to the autocatalytic nature 
of the toxin, it breaks down and the breakdown peptides were tagged. 
Similar to the bands that appeared for the N-term peptides alone, the adherent N-term 
peptides in HeLa cells also had similar bands in the same range when compared to the N-term 
peptide alone bands. Furthermore, bands appeared for the C-terminal domain alone with 
smearing also present with the bands. Again, this may be due to peptide break down. However, 
the protein size of about 99 kDa was clearly visible in the lanes with the C-term peptides added 
to the HeLa cells. The appearance of bands in both the N-term added to HeLa cells and C-term 
added to HeLa cells lanes shows that both the N-term and the C-term peptides were adherent 
proteins and bound to HeLa monolayers. Additionally, in the western blot, the N-term and C-
term were added to empty wells to test to adherence of the peptide to any surface. The lack of 
bands confirmed our assumption that the CptA’s terminal domain peptides did not just adhere to 
any surface. Both the C-term and N-term were adherent to epithelial monolayer cells. 
CptA N-term is hemolytic 
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We incubated the purified CptA peptide with human erythrocyte cells washed in PBS for 
2 hours at 37ºC. The liberated hemoglobin was measured at optic density of 405 nm. In Fig. 8, 
N-terminal domain is hemolytic as a high absorbance was indicative of hemolysis seen at 
500mM dilution with imidazole. N-terminal domain is hemolytic. 
CptA N-term is cytotoxic, and C-term is not cytotoxic 
In Figure 9, The N-term of CptA was cytotoxic and the C-term of CptA was not 
cytotoxic. In Figure 9A, N-term was capable of cell permeabilization and the N-term has an 
affinity for HeLa cell plasma membrane. The N-term permeated epithelial cells as noted by 
trypan exclusion. All the dead cells stained blue. In the HeLa cells in Figure 9B shows C-term 
added to HeLa cells. In Figure 9B, C-term did not permeate cell membrane as noted with less 
death. The C-term bound to some specific host cell receptors on HeLa monolayer cells. In the C-
term, some rounding of the HeLa cells is noticed but not so much, as majority of the cells 
captured have their regular cell morphology that depict tear-shaped angular shaped with growth 
pattern of patchy monolayer. 
C-term inhibited full-length CptA, possible competitive binding mechanism to some host 
surface receptor. 
In Figure 10, C-term peptide to prevent full-length toxin-mediated cytotoxicity. When the 
N-term alone was added to HeLa cells, cell permeabilization was evidenced by trypan blue (Fig. 
10). This supports our hypothesis that N-term peptides have an affinity for plasma membranes. 
We further discovered that when C-term was first added to the HeLa cells before the CptA, we 
discovered that the C-term inhibited the cell permeabilization of the HeLa monolayers. There 
were less cells stained with trypan blue. This lead and supports our hypothesis that C-term may 
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be participating in competitive binding kinetics to host surface receptors on HeLa cells and that 
binding is saturable. 
In-silico analysis for protein structure of CptA 
The results show homologous similarity of CptA structure to full-length FhaB in 
Bordetella as shown in Figure 11. The results also showed that the CptA sequence aligned to 
hemolysin in P. mirabilis. Based on in0silico analysis, 11% of the sequence (215 residues) was 
modelled with 100.0% to a highest scoring template. The proteins structure was modeled after 
template c3fy3A_ ranked #1, and it indicated the whole chain of the protein of modeled protein 
was a toxin, and the PDB molecule was hemolysin with crystal structure of truncated hemolysin 
a from p. mirabilis. The confidence level of the template c3fy3A_was 100, but the % identity 
was 26. Furthermore, based on analysis via the Phyre2.0 software, 772 residues (41%) could be 
modelled at >90% confidence using multiple-templates and 80% of CptA sequence was 
disordered and cannot be meaningfully predicted (Fig. 11). Furthermore, 3% of the sequence was 
alpha helix and 62% beta strands. A second hit was found with 100 confidence level for template 
d1rwra_ with a 29% identity. The second template matching to CptA sequence aligned with 261 
residues, and this template was indicative of a domain of the protein. The template d1rwra_ 
characterized as a single-stranded right-handed beta-helix (Fig. 11). Additionally, the 
superfamily of the template d1rwra_ was Pectin lyase-like, and the family was Filamentous 
hemagglutinin FhaB, which is a secretion domain. 
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Figure 3: Purification of S. amnii full length CptA recombinant proteins 
Figure 3: Purification of S. amnii full length CptA recombinant proteins. Purification of 6X-His 
tagged recombinant CptA expressed in BL21(DE3) pLysS + pRIL strain of E. coli cells 
containing pET32a using a nickel resin column. The samples loaded were compared against Blue 
stain protein ladder molecular weight in the lane 1. The SDS-PAGE gel shows the flow through 
lane in which the initial flow through was saved after passing the filtered lysate through the 
nickel resin beads in lane 2. The remaining lanes show the elution of the bound proteins with 
dilutions of imidazole. The lane 3 represents elution of the bound protein with Ultra-Pure 
distilled water + 10 mM imidazole. The lane 4 represented elution sample with dilution of 100 
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mM imidazole, and the lane 5 represented the sample with dilution of 500 mM imidazole. The 
protein size of CptA was indicated at ~240 kDa (235 kDa). 
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Figure 4: Purification of CptA CTerm (98 kDa) and full-length CptA (235 kDa). 
Figure 4: Purification of CptA CTerm (98 kDa) and full-length CptA (235 kDa). Purification of 
6X-His tagged recombinant CptA expressed in BL21(DE3) pLysS + pRIL strain of E. coli cells 
containing pET32a using a nickel resin column.  The samples loaded were compared against 
BLUEstain protein ladder molecular weight in the first lane. SDS-PAGE analysis of proteins 
eluted from the nickel beads with 125mM, 250 mM, 500mM or 1M imidazole for the both the N-
term and the C-term. The protein size of full-length CptA was indicated at ~240 kDa (235 kDa) 
and the CptA’s C-term domain was indicated at 98 kDa selected in red boxes. 
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Figure 5: Repeated Purification of CptA CTerm (98 kDa) and NTerm (163 kDa). 
Figure 5: Repeated Purification of CptA C-term (98 kDa) and N-term (163 kDa). SDS-PAGE 
analysis of proteins eluted from the nickel beads with 10mM, 100 mM, or 250 mM imidazole. 
Approximate molecular weights are indicated from BLUEstain protein ladder compared to 
samples loaded. 















Figure 6: Adherence of CptA N-Term and C-Term peptides to HeLa cells. 
Figure 6: Adherence of CptA N-Term and C-Term peptides to HeLa cells. Purified peptides were 
either added to HeLa monolayers for 15 minutes or developed as the peptide alone. The adherent 
proteins were developed by western blot. Approximate molecular weights indicated. Lane 1: 
HeLa cells alone; Lane 2: N-term peptides alone; Lane 3: N-term peptides added to HeLa cells; 
Lane 4: C-term peptides alone; Lane 5: C-term peptides added to HeLa cells. 
28 
N-term+ N-term+ C-term+ C-term+ 
MW HeLa N-term HeLa Plastic C-term HeLa Plastic 
Figure 7: Both CptA N-Term and C-Term bind to HeLa cells 
Figure 7: Both CptA N-Term and C-Term bind to HeLa cells. Purified peptides were added to 
HeLa monolayers or empty wells (bare polystyrene). Non-adherent protein was washed away, 
and adherent protein was detected by Western blot. Lane 1: HeLa cells alone; Lane 2: N-term 
peptides alone; Lane 3: N-term peptides added to HeLa cells; Lane 4: N-term peptides added to 
bare polystyrene wells; Lane 5: C-term peptides alone; Lane 6: C-term peptides added to HeLa 
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Figure 8: Full Length CptA hemolytic activity on human red blood cells. 
Figure 8: Full Length CptA hemolytic activity on human red blood cells. A hemolytic assay was 
performed by incubating full length CptA saved from the purification steps with human 
erythrocyte cells washed in PBS and incubated for 2 hours at 37ºC. The liberated hemoglobin 
















Figure 9: Cytotoxic assay using N-terminal and C-terminal domain of CptA 
Figure 9: Cytotoxic assay using N-terminal and C-terminal domain of CptA. The HeLa 
monolayers were washed with PBS and incubated with the purified peptides in a 5% CO2 
incubator at 37C for 2 hours. The cells were assessed using trypan blue exclusion and viewed 
under an inverted microscopy. Fig. 9A shows N-term/ CptA added to HeLa cells and Fig. 9B 
shows C-term added to HeLa cells. N-terminal domain has an affinity for plasma membrane. 
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Figure 10: CptA’s C-term blocked cytotoxic activity of full-length CptA in HeLa Cells. 
Figure 10: CptA’s C-term blocked cytotoxic activity of full-length CptA in HeLa Cells. HeLa 
cells were washed with PBS and incubated with the purified peptides in a 5% CO2 incubator at 
37C for 2 hours. The cells were stained with trypan blue exclusion and viewed under an 
inverted microscopy. C-term peptide prevented full-length toxin-mediated cytotoxicity. 
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Figure 11: Homology model of full length CptA toxin modeled after c3fy3A_. 
Figure 11: Homology model of full length CptA toxin modeled after highest score template 
c3fy3A_ using Phyre2.0 prediction protein modeling software. The template c3fy3A_ was a 
truncated protein from P. mirabilis. 
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Discussion 
In the current study, we had the initial focus to characterize the CptA of S. amnii. The 
first research focus was to express the full-length CptA and the domains of CptA (N-term and C-
term) in pET32a expression vectors in E. coli cells. It was hypothesized that E. coli cells could 
express the full-length peptides and domain peptides. This hypothesis was confirmed, as the 
SDS-PAGE gel analysis showed that the recombinant proteins were successfully expressed in 
BL21(DE3) pLysS + pRIL E. coli cells and purified by nickel ion column. In this experiment, we 
faced obstacles that included smearing of the proteins in the lane as well as the appearance of the 
other bands that were not the recorded protein size. While we were not able to determine the 
reason that the other bands showed up, we assumed that this may be due to the breakdown of the 
protein. 
In the second objective, the focus of the study was to determine which domain of CptA is 
responsible for the cytotoxic and hemolytic activity. The data of this study contributes a clearer 
understanding of the roles of the CptA. We confirmed our hypothesis that CptA is hemolytic and 
that the N-terminal domain that codes for CptA was also hemolytic as it had an affinity for 
plasma membrane allowing the protein to perforate epithelial cell monolayers. While previous 
research (Gentile et al. 2020) has focused on CptA, these results of this experiment demonstrate 
that even the separable domains of CptA retain their function. Our work has revealed that the C-
terminal domain is involved in binding to the host cell surface and that the N-terminal domain is 
the pore-forming domain. The results indicate that the C-terminal domain peptides was not 
cytotoxic and has a role in binding to some specific host cell receptor on epithelial cells. 
Additionally, our findings supported the theory of full-length having hemolytic and 
cytotoxic effects on epithelial cells through in-silico analysis. Based on in-silico analysis of full 
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length CptA, it was reported that CptA was homologous with a small portion of a truncated 
hemolysin found in P. mirabilis. The in-silico analysis also matched a region of the secretion 
domain, Filamentous hemagglutinin (FhaB), in Bordetella species. Thus, the similar structural 
homology present supports in our Phyre 2.0 supports past studies that note that CptA toxin is 
secreted through a Type Vb two-partner secretion system where the effector, CptA which is 
homologous to Fha in Bordetella pertussis, is secreted by a transporter similar to FhaC in 
Bordetella pertussis. 
In the third objective of this study, the focus was to characterize the role C-term plays in 
cytotoxicity. It was determined that C-term can prevent full-length CptA mediated cytotoxicity 
through competitive binding kinetics with some host cell surface receptors. Currently, it is not 
known what the host cell receptor in the protein-host binding interactions is. Therefore, further 
studies can be done to determine the specific host receptor as well as determine cytotoxicity over 
a longer period. Additionally, different epithelial cells can be used as model cell lines in the 
research. In future studies, C-term can be added first and incubated for a longer period to achieve 
saturation before CptA is added. 
Other future works to advance the studies also include using CptA proximal binding 
partners on the target cells to determine structural protein composition via mass spectrometry to 
further understand how the toxin works and its function. Second, we can adapt methodology to 
determine the best way to purify the product with less breakdown protein. Lastly, further 
research can be done to design therapies to treat and prevent the prevalence of Sneathia species, 
which is common in the vaginal microbiome and prevalent in women of African ancestry. 
Sneathia amnii has been implicated in gynecologic and obstetric complications associated 
with the vaginal microbiome. Sneathia amnii is categorized as a pathogenic anaerobe that 
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ascends the uterine cavity into sterile environments of the cervix and traverses epithelial cells to 
cross into amniotic fluid where it can be detected (Jefferson 2012). Although the specific role of 
Sneathia amnii is still being explored, our study has started to characterize the components of 
CptA and its role in idiopathic conditions like PTB and BV. Sneathia amnii is implicated in 
intrauterine infections and inflammations which are linked to preterm birth and prevalent in 
women of African ancestry (Jefferson 2012; Fettweis et al. 2014). Because women of African 
descent are more likely to develop BV, which is a gateway to more adverse outcomes including 
pregnancy complications. Studying S. amnii, its cytotoxin, and the role the bacteria plays in 
preterm-birth complication is essential in mitigating derived idiopathic conditions as well as 
reducing the overall rate of PTB as well as the health costs attributed to preterm birth deliveries. 
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